...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum.
【24h】

Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum.

机译:腹侧被盖区的兴奋性氨基酸受体调节腹侧纹状体中的多巴胺释放。

获取原文
获取原文并翻译 | 示例

摘要

The role of excitatory amino acid (EAA) receptors located in the ventral tegmental area (VTA) in tonic and phasic regulation of dopamine release in the ventral striatum was investigated. Microdialysis in conscious rats was used to assess dopamine release primarily from the nucleus accumbens shell region of the ventral striatum while applying EAA antagonists or agonists to the VTA. Infusion of the AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (25 and 100 microM) into the VTA did not affect dopamine release in the ventral striatum. In contrast, intra-VTA infusion of the NMDA receptor antagonist 2-amino-5-phosphopentanoic acid (100 and 500 microM) dose-dependently decreased the striatal release of dopamine. Intra-VTA application of the ionotropic EAA receptor agonists NMDA and AMPA dose-dependently (10 and 100 microM) increased dopamine efflux in the ventral striatum. However, infusion of 50 or 500 microM trans-(+/-)-1-amino-1,3-cyclopentanedicarboxylic acid (ACPD), a metabotropic EAA receptor agonist, did not significantly affect these levels. These data suggest that NMDA receptors in the VTA exert a tonic excitatory influence on dopamine release in the ventral striatum. Furthermore, dopamine neurotransmission in this region may be enhanced by activation of NMDA and AMPA receptors, but not ACPD-sensitive metabotropic receptors, located in the VTA. These data further suggest that EAA regulation of dopamine release primarily occurs in the VTA as opposed to presynaptically at the terminal level.
机译:研究了位于腹侧被盖区(VTA)的兴奋性氨基酸(EAA)受体在腹侧纹状体中多巴胺释放的补品和阶段性调节中的作用。在有意识的大鼠中进行微透析,以评估多巴胺主要从腹侧纹状体伏隔核壳区域释放多巴胺,同时将EAA拮抗剂或激动剂应用于VTA。将VPA /海藻酸酯受体拮抗剂6-氰基-7-硝基喹喔啉-2,3-二酮(25和100 microM)注入VTA不会影响腹侧纹状体中的多巴胺释放。相反,VDA内注入NMDA受体拮抗剂2-氨基-5-磷酸戊酸(100和500 microM)剂量依赖性地减少了多巴胺的纹状体释放。离子型EAA受体激动剂NMDA和AMPA的VTA内剂量依赖性(10和100 microM)增加腹侧纹状体中的多巴胺外排。但是,输注50或500 microM反-(+/-)-1-氨基-1,3-环戊烷二羧酸(ACPD),一种促代谢型EAA受体激动剂,并没有显着影响这些水平。这些数据表明,VTA中的NMDA受体对腹侧纹状体中的多巴胺释放具有兴奋性兴奋作用。此外,该区域中的多巴胺神经传递可通过激活位于VTA中的NMDA和AMPA受体而不是ACPD敏感的代谢型受体来增强。这些数据进一步表明,多巴胺释放的EAA调节主要发生在VTA中,而不是在末端水平突触。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号